BPTS
Biophytis SA ADR

765
Loading...
Loading...
Biophytis SA operates as a clinical-stage biotechnology company. It specializes in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19. Its products include Sarconeos (BIO101), which is used to treat sarcopenic obesity and Macuneos (BIO201), which is used to treat dry age-related macular degeneration (AMD). The company was founded by Stanislas Veillet and René Lafont on September 27, 2006 and is headquartered in Paris, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
20

Frequently Asked Questions

What is Market Cap of Biophytis - ADR?
What is the 52-week high for Biophytis - ADR?
What is the 52-week low for Biophytis - ADR?
What is Biophytis - ADR stock price today?
What was Biophytis - ADR stock price yesterday?
What is the PE ratio of Biophytis - ADR?
What is the Price-to-Book ratio of Biophytis - ADR?
What is the 50-day moving average of Biophytis - ADR?
How many employess does Biophytis - ADR has?

Latest BPTS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.